Humanwell Healthcare Group Co Ltd
SSE:600079

Watchlist Manager
Humanwell Healthcare Group Co Ltd Logo
Humanwell Healthcare Group Co Ltd
SSE:600079
Watchlist
Price: 22.49 CNY -4.22% Market Closed
Market Cap: 36.4B CNY
Have any thoughts about
Humanwell Healthcare Group Co Ltd?
Write Note

Humanwell Healthcare Group Co Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Humanwell Healthcare Group Co Ltd
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Humanwell Healthcare Group Co Ltd
SSE:600079
Cash from Investing Activities
-ÂĄ1.2B
CAGR 3-Years
N/A
CAGR 5-Years
-10%
CAGR 10-Years
1%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Cash from Investing Activities
ÂĄ1.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Cash from Investing Activities
ÂĄ7B
CAGR 3-Years
N/A
CAGR 5-Years
66%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Cash from Investing Activities
-ÂĄ1.9B
CAGR 3-Years
N/A
CAGR 5-Years
9%
CAGR 10-Years
-25%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Cash from Investing Activities
ÂĄ5.9m
CAGR 3-Years
-88%
CAGR 5-Years
-80%
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Cash from Investing Activities
-ÂĄ81.9m
CAGR 3-Years
27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Humanwell Healthcare Group Co Ltd
Glance View

Market Cap
36.7B CNY
Industry
Pharmaceuticals

Humanwell Healthcare (Group) Co., Ltd. engages in the research and development, production, and sale of medical products. The company is headquartered in Wuhan, Hubei and currently employs 15,746 full-time employees. The Company’s products are categorized into chemical drugs, chemical raw material medicines, traditional Chinese medicines, biological medicines and others. The firm also provides medical instruments. The firm distributes its products in both domestic market and to overseas markets.

Intrinsic Value
36.93 CNY
Undervaluation 39%
Intrinsic Value
Price

See Also

What is Humanwell Healthcare Group Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-1.2B CNY

Based on the financial report for Sep 30, 2024, Humanwell Healthcare Group Co Ltd's Cash from Investing Activities amounts to -1.2B CNY.

What is Humanwell Healthcare Group Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
1%

Over the last year, the Cash from Investing Activities growth was -92%.

Back to Top